Project Details
| Status | Active |
|---|---|
| Effective start/end date | 6/29/21 → 6/29/24 |
Funding
- Rho, Inc. (Prot #UBX1325-02)
- Unity Biotechnology, Inc (Prot #UBX1325-02)
Prot #UBX1325-02: Phase 2a, Prospective, Multicenter, Randomized, Double Masked, Sham-Controlled Study to Assess the Safety, Tolerability and Evidence of Activity of a Single Intravitreal Injection of UBX1325 in Patients with Diabetic Macular Edema,
- Gill, Manjot K (PD/PI)
Project: Research project